346434798	346434798	CD	B-NP	O
|	|	NNP	I-NP	O
WCEMC	WCEMC	NNP	I-NP	O
|	|	VBD	B-VP	O
55985231	55985231	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
8003998	8003998	CD	B-NP	O
|	|	CC	I-NP	O
2/10/2003	2/10/2003	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
UNSTABLE	UNSTABLE	NNP	I-NP	I-protein
ANGINA	ANGINA	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/26/2003	6/26/2003	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/29/2003	9/29/2003	CD	B-NP	O
CHIEF	CHIEF	NN	I-NP	O
COMPLAINT	COMPLAINT	NN	I-NP	O
:	:	:	O	O
CHEST	CHEST	NN	B-NP	B-protein
PAIN	PAIN	NN	I-NP	I-protein
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
Ms.	Ms.	NNP	B-NP	O
Dube	Dube	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
58-year-old	58-year-old	JJ	I-NP	O
female	female	JJ	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
stent	stent	NN	I-NP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
left	left	JJ	I-NP	O
circumflex	circumflex	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
three	three	CD	B-NP	O
months	month	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
non-insulin	non-insulin	JJ	B-NP	O
dependent	dependent	JJ	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
hyperlipidemia	hyperlipidemia	NN	B-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
left	left	JJ	B-NP	O
jaw	jaw	NN	I-NP	O
pain	pain	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
several	several	JJ	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
treated	treat	VBD	B-VP	O
this	this	DT	B-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
with	with	IN	B-PP	O
sublingual	sublingual	JJ	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
with	with	IN	B-PP	O
partial	partial	JJ	B-NP	O
relief	relief	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
full	full	JJ	B-NP	O
resolution	resolution	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
jaw	jaw	NN	I-NP	O
pain	pain	NN	I-NP	O
with	with	IN	B-PP	O
three	three	CD	B-NP	O
sublingual	sublingual	JJ	I-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
non-ST	non-ST	JJ	I-NP	O
elevation	elevation	NN	I-NP	O
MI	MI	NN	I-NP	O
approximately	approximately	RB	B-NP	O
three	three	CD	I-NP	O
months	month	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
left	leave	VBN	I-VP	O
jaw	jaw	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

Since	Since	IN	B-SBAR	O
this	this	DT	B-NP	O
pain	pain	NN	I-NP	O
was	be	VBD	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
classic	classic	JJ	I-NP	O
anginal	anginal	JJ	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
heparin	heparin	NN	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
despite	despite	IN	B-PP	O
the	the	DT	B-NP	O
fact	fact	NN	I-NP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	B-protein
had	have	VBD	B-VP	I-protein
negative	negative	JJ	B-NP	I-protein
cardiac	cardiac	JJ	I-NP	I-protein
enzymes	enzyme	NNS	I-NP	I-protein
and	and	CC	O	O
no	no	DT	B-NP	O
EKG	EKG	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Non-insulin	Non-insulin	NN	B-NP	B-protein
dependent	dependent	JJ	I-NP	O
diabetes	diabete	NNS	I-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
hyperlipidemia	hyperlipidemia	NN	B-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
left	leave	VBD	B-VP	O
circumflex	circumflex	NN	B-NP	O
stent	stent	NN	I-NP	O
in	in	IN	B-PP	O
April	April	NNP	B-NP	O
2002	2002	CD	I-NP	O
.	.	.	O	O

Anxiety	Anxiety	NN	B-NP	O
,	,	,	O	O
depression	depression	NN	B-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
arm	arm	NN	B-NP	O
phlebitis	phlebitis	NN	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
blood	blood	NN	B-NP	O
draws	draw	NNS	I-NP	O
after	after	IN	B-PP	O
her	her	PRP$	B-NP	O
left	left	JJ	I-NP	O
circumflex	circumflex	NN	I-NP	O
stent	stent	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	NN	I-NP	O
appendectomy	appendectomy	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
tubal	tubal	JJ	I-NP	O
ligation	ligation	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
Glucophage	Glucophage	NN	B-NP	O
,	,	,	O	O
Lipitor	Lipitor	NN	B-NP	O
,	,	,	O	O
atenolol	atenolol	NN	B-NP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
sublingual	sublingual	JJ	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
,	,	,	O	O
Zestril	Zestril	NNP	B-NP	O
,	,	,	O	O
Celexa	Celexa	NNP	B-NP	O
,	,	,	O	O
Klonopin	Klonopin	NNP	B-NP	O
,	,	,	O	O
Neurontin	Neurontin	NNP	B-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
daughter	daughter	NN	I-NP	O
who	who	WP	B-NP	O
works	work	VBZ	B-VP	O
for	for	IN	B-PP	O
Erdar	Erdar	NNP	B-NP	O
Y	Y	NNP	I-NP	O
University	University	NNP	I-NP	O
Hospitals	Hospitals	NNP	I-NP	O
She	She	NNP	I-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
smoke	smoke	VB	I-VP	O
nor	nor	CC	O	O
does	do	VBZ	O	O
she	she	PRP	B-NP	O
drink	drink	VB	B-VP	O
alcohol	alcohol	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
language	language	NN	I-NP	O
is	be	VBZ	B-VP	O
Spanish	Spanish	JJ	B-ADJP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Positive	Positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
father	father	NN	I-NP	O
died	die	VBD	B-VP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
at	at	IN	B-PP	O
age	age	NN	B-NP	O
62	62	CD	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
mother	mother	NN	I-NP	O
died	die	VBD	B-VP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
at	at	IN	B-PP	O
age	age	NN	B-NP	O
75	75	CD	I-NP	O
.	.	.	O	O

VITAL	VITAL	JJ	B-NP	O
SIGNS	SIGNS	NN	I-NP	O
:	:	:	O	O
Blood	Blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
100-137/52	100-137/52	CD	B-NP	O
-67	-67	CD	I-NP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
60-62	60-62	CD	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
18	18	CD	I-NP	O
,	,	,	O	O
oxygen	oxygen	NN	B-NP	O
saturation	saturation	NN	I-NP	O
97-98	97-98	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
two	two	CD	B-NP	O
liters	liter	NNS	I-NP	O
nasal	nasal	JJ	I-NP	O
cannula	cannula	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
GENERAL	GENERAL	NNP	B-NP	O
:	:	:	O	O
Well	Well	NNP	B-NP	O
appearing	appear	VBG	B-VP	O
middle-aged	middle-aged	JJ	B-NP	O
female	female	NN	I-NP	O
.	.	.	O	O

NECK	NECK	NN	B-NP	O
:	:	:	O	O
JVP	JVP	NN	B-NP	O
flat	flat	NN	I-NP	O
.	.	.	O	O

CARDIOVASCULAR	CARDIOVASCULAR	NN	B-NP	O
:	:	:	O	O
Regular	Regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	O	O
rhythm	rhythm	NN	B-NP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
S1	S1	NN	I-NP	B-protein
and	and	CC	I-NP	O
S2	S2	NN	I-NP	B-protein
.	.	.	O	O

CHEST	CHEST	NN	B-NP	O
:	:	:	O	O
Clear	Clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

ABDOMEN	ABDOMEN	NN	B-NP	O
:	:	:	O	O
Soft	Soft	JJ	B-NP	O
,	,	,	I-NP	O
nontender	nontender	JJ	I-NP	O
,	,	,	I-NP	O
nondistended	nondistended	JJ	I-NP	O
.	.	.	O	O

Positive	Positive	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

EXTREMITIES	EXTREMITIES	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
warm	warm	NN	B-NP	O
.	.	.	O	O

RECTAL	RECTAL	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
guaiac	guaiac	NN	B-NP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
BY	BY	NNP	I-NP	O
SYSTEMS	SYSTEMS	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
for	for	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
after	after	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
April	April	NNP	B-NP	O
,	,	,	O	O
2003	2003	CD	B-NP	O
.	.	.	O	O

Prior	Prior	RB	B-ADVP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
catheterization	catheterization	NN	I-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
enrolled	enrol	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Nacan	Nacan	NNP	I-NP	O
Cajord	Cajord	NNP	I-NP	O
General	General	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
This	This	NNP	I-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
blinded	blinded	JJ	I-NP	O
trial	trial	NN	I-NP	O
with	with	IN	B-PP	O
Permsan	Permsan	NNP	B-NP	O
Madiston	Madiston	NNP	I-NP	O
Ni	Ni	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
accordance	accordance	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
trial	trial	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Lovenox	Lovenox	NN	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
per	per	IN	B-PP	O
kg	kg	NN	B-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
Later	Later	RB	I-ADVP	O
that	that	IN	B-SBAR	O
afternoon	afternoon	NN	B-NP	O
on	on	IN	B-PP	O
April	April	NNP	B-NP	O
,	,	,	O	O
2003	2003	CD	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
went	go	VBD	B-VP	O
for	for	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
cath	cath	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
dominant	dominant	JJ	I-NP	O
system	system	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
left	left	JJ	I-NP	O
main	main	JJ	I-NP	O
lesions	lesion	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
left	left	JJ	I-NP	O
anterior	anterior	JJ	I-NP	O
descending	descend	VBG	I-NP	O
lesions	lesion	NNS	I-NP	O
,	,	,	O	O
70	70	CD	B-NP	O
%	%	NN	I-NP	O
diffuse	diffuse	JJ	I-NP	O
lesion	lesion	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
circumflex	circumflex	NN	I-NP	O
artery	artery	NN	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
instant	instant	JJ	B-NP	O
restenosis	restenosis	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP	B-NP	O
previously	previously	RB	I-NP	O
placed	place	VBN	I-NP	O
PIXEL	PIXEL	NN	I-NP	O
stent	stent	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
right	right	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
30	30	CD	I-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
this	this	DT	B-NP	O
catheterization	catheterization	NN	I-NP	O
,	,	,	O	O
brachytherapy	brachytherapy	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
vessel	vessel	NN	I-NP	O
that	that	WDT	B-NP	O
showed	show	VBD	B-VP	O
instant	instant	JJ	B-NP	O
restenosis	restenosis	NN	I-NP	O
was	be	VBD	B-VP	O
attempted	attempt	VBN	I-VP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
aborted	abort	VBN	I-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
technical	technical	JJ	B-NP	O
malfunction	malfunction	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
brachytherapy	brachytherapy	NN	I-NP	O
delivery	delivery	NN	I-NP	O
machine	machine	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
lesion	lesion	NN	I-NP	O
was	be	VBD	B-VP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
dilated	dilate	VBN	B-VP	O
by	by	IN	B-PP	O
balloon	balloon	NN	B-NP	O
angioplasty	angioplasty	NN	I-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
dilatation	dilatation	NN	B-NP	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
TIMI-3	TIMI-3	NN	B-NP	O
flow	flow	NN	I-NP	O
with	with	IN	B-PP	O
10	10	CD	B-NP	O
%	%	NN	I-NP	O
residual	residual	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
.	.	.	O	O

Postcath	Postcath	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
Zocor	Zocor	NN	B-NP	O
,	,	,	O	O
Lopressor	Lopressor	NN	B-NP	O
,	,	,	O	O
captopril	captopril	NN	B-NP	O
,	,	,	O	O
Celexa	Celexa	NNP	B-NP	O
,	,	,	O	O
Klonopin	Klonopin	NNP	B-NP	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
morning	morning	NN	I-NP	O
after	after	IN	B-PP	O
catheterization	catheterization	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
recurrent	recurrent	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
which	which	WDT	B-NP	O
radiated	radiate	VBD	B-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
right	right	JJ	I-NP	O
jaw	jaw	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
pain	pain	NN	I-NP	O
was	be	VBD	B-VP	O
relieved	relieve	VBN	I-VP	O
with	with	IN	B-PP	O
sublingual	sublingual	JJ	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
following	follow	VBG	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
develop	develop	VB	I-VP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
groin	groin	NN	I-NP	O
hematoma	hematoma	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
afternoon	afternoon	NN	I-NP	O
on	on	IN	B-PP	O
July	July	NNP	B-NP	O
,	,	,	O	O
2003	2003	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
hematoma	hematoma	NN	I-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
rapidly	rapidly	RB	B-ADVP	O
enlarging	enlarge	VBG	B-VP	O
.	.	.	O	O

Hematocrit	Hematocrit	NN	B-NP	O
checked	check	VBD	B-VP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
drop	drop	NN	I-NP	O
in	in	IN	B-PP	O
blood	blood	NN	B-NP	O
count	count	NN	I-NP	O
to	to	TO	B-PP	O
26	26	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
transfused	transfuse	VBN	I-VP	O
two	two	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
packed	packed	JJ	B-NP	B-cell_type
red	red	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Her	Her	PRP$	B-NP	O
hematoma	hematoma	NN	I-NP	O
continue	continue	VBP	B-VP	O
to	to	TO	I-VP	O
expand	expand	VB	I-VP	O
overnight	overnight	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
from	from	IN	B-PP	O
Lovenox	Lovenox	NN	B-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
and	and	CC	I-NP	O
Plavix	Plavix	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
Lovenox	Lovenox	NN	I-NP	O
was	be	VBD	B-VP	O
reversed	reverse	VBN	I-VP	O
with	with	IN	B-PP	O
protamine	protamine	NN	B-NP	O
.	.	.	O	O

Over	Over	IN	B-PP	O
the	the	DT	B-NP	O
night	night	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
hematoma	hematoma	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
expand	expand	VB	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
received	receive	VBD	B-VP	O
,	,	,	O	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
morning	morning	NN	I-NP	O
on	on	IN	B-PP	O
March	March	NNP	B-NP	O
,	,	,	O	O
2003	2003	CD	B-NP	O
,	,	,	O	O
one	one	CD	B-NP	O
unit	unit	NN	I-NP	O
of	of	IN	B-PP	O
fresh	fresh	JJ	B-NP	O
frozen	frozen	JJ	I-NP	O
plasma	plasma	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
third	third	JJ	I-NP	O
unit	unit	NN	I-NP	O
of	of	IN	B-PP	O
packed	packed	JJ	B-NP	B-cell_type
red	red	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

At	At	IN	B-PP	O
that	that	DT	B-NP	O
point	point	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
hematoma	hematoma	NN	I-NP	O
was	be	VBD	B-VP	O
marked	mark	VBN	I-VP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
stable	stable	JJ	B-ADJP	O
from	from	IN	B-PP	O
that	that	DT	B-NP	O
point	point	NN	I-NP	O
on	on	IN	B-PP	O
,	,	,	O	O
no	no	RB	B-ADVP	O
longer	longer	RB	I-ADVP	O
expanding	expand	VBG	B-VP	O
beyond	beyond	IN	B-PP	O
the	the	DT	B-NP	O
bounds	bound	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
marks	mark	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
left	left	JJ	I-NP	O
arm	arm	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
to	to	TO	B-VP	O
also	also	RB	I-VP	O
be	be	VB	I-VP	O
tense	tense	JJ	B-ADJP	O
with	with	IN	B-PP	O
hematoma	hematoma	NN	B-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
blood	blood	NN	B-NP	O
draws	draw	NNS	I-NP	O
.	.	.	O	O

Vascular	Vascular	JJ	B-NP	O
surgery	surgery	NN	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
on	on	IN	B-PP	O
March	March	NNP	B-NP	O
,	,	,	O	O
2003	2003	CD	B-NP	O
,	,	,	O	O
in	in	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
groin	groin	NN	I-NP	O
hematoma	hematoma	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
the	the	DT	B-NP	O
hematoma	hematoma	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
arm	arm	NN	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
concern	concern	NN	B-NP	O
for	for	IN	B-PP	O
developing	develop	VBG	B-VP	O
compartment	compartment	NN	B-NP	O
syndrome	syndrome	NN	I-NP	O
.	.	.	O	O

Vascular	Vascular	JJ	B-NP	O
surgery	surgery	NN	I-NP	O
saw	see	VBD	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
and	and	CC	O	O
felt	feel	VBD	B-VP	O
that	that	IN	B-SBAR	O
as	as	RB	B-ADVP	O
long	long	RB	I-ADVP	O
as	as	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
stabilized	stabilize	VBD	B-VP	O
,	,	,	O	O
she	she	PRP	B-NP	O
would	would	MD	B-VP	O
not	not	RB	I-VP	O
need	need	VB	I-VP	O
any	any	DT	B-NP	O
surgical	surgical	JJ	I-NP	O
intervention	intervention	NN	I-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
could	could	MD	B-VP	O
not	not	RB	I-VP	O
find	find	VB	I-VP	O
any	any	DT	B-NP	O
evidence	evidence	NN	I-NP	O
for	for	IN	B-PP	O
left	left	JJ	B-NP	O
upper	upper	JJ	I-NP	O
extremity	extremity	NN	I-NP	O
compartment	compartment	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
of	of	IN	B-PP	O
March	March	NNP	B-NP	O
,	,	,	O	O
2003	2003	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
platelets	platelet	NNS	I-NP	O
agents	agent	NNS	I-NP	O
including	include	VBG	B-PP	O
both	both	CC	O	O
Plavix	Plavix	NN	B-NP	O
and	and	CC	I-NP	O
aspirin	aspirin	NN	I-NP	O
were	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
.	.	.	O	O

Further	Further	JJ	B-NP	O
family	family	NN	I-NP	O
history	history	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
that	that	IN	B-SBAR	O
day	day	NN	B-NP	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
history	history	NN	B-NP	O
suspicious	suspicious	JJ	B-ADJP	O
for	for	IN	B-PP	O
possible	possible	JJ	B-NP	O
bleeding	bleeding	NN	I-NP	O
disorder	disorder	NN	I-NP	O
including	include	VBG	B-PP	O
the	the	DT	B-NP	O
information	information	NN	I-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
daughter	daughter	NN	I-NP	O
bleeds	bleed	VBZ	B-VP	O
heavily	heavily	RB	B-ADVP	O
with	with	IN	B-PP	O
each	each	DT	B-NP	O
menstrual	menstrual	JJ	I-NP	O
period	period	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
both	both	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
daughter	daughter	NN	I-NP	O
have	have	VBP	B-VP	O
very	very	RB	B-NP	O
easy	easy	JJ	I-NP	O
bruising	bruising	NN	I-NP	O
with	with	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
several	several	JJ	B-NP	O
hematomas	hematoma	NNS	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
light	light	JJ	B-NP	O
trauma	trauma	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
reported	report	VBD	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
heavy	heavy	JJ	B-NP	O
bleeding	bleeding	NN	I-NP	O
with	with	IN	B-PP	O
childbirth	childbirth	NN	B-NP	O
that	that	WDT	B-NP	O
required	require	VBD	B-VP	O
extra	extra	JJ	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
although	although	IN	B-SBAR	O
it	it	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
require	require	VB	I-VP	O
a	a	DT	B-NP	O
transfusion	transfusion	NN	I-NP	O
.	.	.	O	O

Hematology	Hematology	NN	B-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
point	point	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
by	by	IN	B-PP	O
hematology	hematology	NN	B-NP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
these	these	DT	B-NP	O
hematomas	hematoma	NNS	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
over	over	IN	B-PP	O
anticoagulation	anticoagulation	NN	B-NP	O
with	with	IN	B-PP	O
Lovenox	Lovenox	NNP	B-NP	O
,	,	,	I-NP	O
Plavix	Plavix	NNP	I-NP	O
,	,	,	I-NP	O
aspirin	aspirin	NN	I-NP	O
and	and	CC	O	O
possible	possible	JJ	B-NP	O
STONDE	STONDE	NN	I-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
CENTER	CENTER	NNP	I-NP	O
trial	trial	NN	I-NP	O
drug	drug	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
Kenda	Kenda	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
The	The	DT	B-NP	O
only	only	RB	I-NP	O
familial	familial	JJ	I-NP	O
coagulation	coagulation	NN	I-NP	O
problems	problem	NNS	I-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
screened	screen	VBN	I-VP	O
for	for	IN	B-PP	O
based	base	VBN	B-VP	O
on	on	IN	B-PP	O
their	their	PRP$	B-NP	O
recommendations	recommendation	NNS	I-NP	O
were	be	VBD	B-VP	O
von	von	NNP	B-NP	O
Willebrand	Willebrand	NNP	I-NP	O
screen	screen	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
Factor	Factor	NN	I-NP	O
XIII	XIII	NN	I-NP	O
screen	screen	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Factor	Factor	NN	I-NP	O
XIII	XIII	NN	I-NP	O
screen	screen	NN	I-NP	O
eventually	eventually	RB	B-ADVP	O
turned	turn	VBD	B-VP	O
out	out	RP	B-PRT	O
normal	normal	JJ	B-ADJP	O
and	and	CC	O	O
the	the	DT	B-NP	O
von	von	NN	I-NP	O
Willebrand	Willebrand	NN	I-NP	O
screen	screen	NN	I-NP	O
was	be	VBD	B-VP	O
pending	pende	VBG	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

By	By	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
of	of	IN	B-PP	O
August	August	NNP	B-NP	O
,	,	,	O	O
2003	2003	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
received	receive	VBN	I-VP	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
five	five	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
packed	packed	JJ	B-NP	B-cell_type
red	red	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
blood	blood	NN	B-NP	O
loss	loss	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
hematoma	hematoma	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
hematoma	hematoma	NN	I-NP	O
had	have	VBD	B-VP	O
stabilized	stabilize	VBN	I-VP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
on	on	IN	B-PP	O
August	August	NNP	B-NP	O
,	,	,	O	O
2003	2003	CD	B-NP	O
.	.	.	O	O

From	From	IN	B-PP	O
that	that	DT	B-NP	O
point	point	NN	I-NP	O
onward	onward	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
quite	quite	RB	B-ADVP	O
well	well	RB	I-ADVP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
beta-blocker	beta-blocker	NN	B-NP	O
,	,	,	O	O
Zocor	Zocor	NN	B-NP	O
and	and	CC	O	O
ACE	ACE	NN	B-NP	O
inhibitor	inhibitor	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
remainder	remainder	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
was	be	VBD	B-VP	O
uncomplicated	uncomplicated	JJ	B-ADJP	O
and	and	CC	O	O
after	after	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
stable	stable	JJ	I-NP	O
hematocrit	hematocrit	NN	I-NP	O
for	for	IN	B-PP	O
several	several	JJ	B-NP	O
days	day	NNS	I-NP	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
recurrent	recurrent	JJ	I-NP	O
jaw	jaw	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
home	home	NN	B-ADVP	O
on	on	IN	B-PP	O
January	January	NNP	B-NP	O
,	,	,	O	O
2003	2003	CD	B-NP	O
.	.	.	O	O

Neurology	Neurology	NNP	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
August	August	NNP	B-NP	O
,	,	,	O	O
2003	2003	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
developed	develop	VBD	B-VP	O
a	a	DT	B-NP	O
headache	headache	NN	I-NP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
described	describe	VBD	B-VP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
as	as	IN	B-PP	O
she	she	PRP	B-NP	O
frequently	frequently	RB	B-ADVP	O
experiences	experience	VBZ	B-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
headaches	headache	NNS	I-NP	O
are	be	VBP	B-VP	O
usually	usually	RB	B-ADVP	O
not	not	RB	O	O
responsive	responsive	JJ	B-ADJP	O
to	to	TO	B-PP	O
Tylenol	Tylenol	NN	B-NP	O
or	or	CC	O	O
other	other	JJ	B-NP	O
analgesics	analgesic	NNS	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
complications	complication	NNS	I-NP	O
with	with	IN	B-PP	O
hematoma	hematoma	NN	B-NP	O
and	and	CC	I-NP	O
bleeding	bleeding	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
head	head	NN	I-NP	O
CT	CT	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
that	that	IN	B-SBAR	O
afternoon	afternoon	NN	B-NP	O
to	to	TO	B-VP	O
rule	rule	VB	I-VP	O
out	out	RP	B-PRT	O
intracerebral	intracerebral	JJ	B-NP	O
hemorrhage	hemorrhage	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
head	head	NN	I-NP	O
CT	CT	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
bleeding	bleed	VBG	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
headache	headache	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
Tylenol	Tylenol	NN	B-NP	O
to	to	TO	B-PP	O
which	which	WDT	B-NP	O
it	it	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
respond	respond	VB	I-VP	O
and	and	CC	O	O
later	later	RBR	B-ADVP	O
with	with	IN	B-PP	O
Percocet	Percocet	NNP	B-NP	O
to	to	TO	B-PP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
got	get	VBD	B-VP	O
some	some	DT	B-NP	O
relief	relief	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Aspirin	Aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q	q	NN	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Klonopin	Klonopin	NN	B-NP	O
0.5	0.5	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
glucophage	glucophage	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Celexa	Celexa	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Zestril	Zestril	NNP	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
atenolol	atenolol	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Lipitor	Lipitor	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
instructed	instruct	VBN	I-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Bazer	Bazer	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
LUKE	LUKE	NNP	B-NP	O
DRENTLAW	DRENTLAW	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
SN01	SN01	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
MARK	MARK	NNP	B-NP	O
WILKES	WILKES	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
JO16	JO16	NNP	I-NP	O
LY565/943229	LY565/943229	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
71748	71748	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

NNAJ9W4537	NNAJ9W4537	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
5/5/03	5/5/03	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
5/5/03	5/5/03	CD	B-NP	O

